The Globe and Mail reports in its Thursday, Dec. 14, edition that Stifel analyst Cole Pereira has reaffirmed his "buy" recommendation on Keyera. The Globe's David Leeder writes in the Eye On Equities coplumn that Mr. Pereira cut his Keyera share target to $38.50 from $39. Analysts on average target the shares at $35.54. Mr. Cole says in a note: "Keyera unveiled a prudent 2024 capital plan of $170-million to $210-million vs $295-million to $335-million in 2023, while also raising its long-term marketing guidance and indicating it should be at the high end of its 2022-2025 adjusted EBITDA CAGR of 6-7 per cent (Stifel: 7.1 per cent). We believe Keyera's decision to push out the sanctioning timeline for KAPS Zone 4 and a KFS expansion reflects its desire to (1) meet required contracting thresholds for Zone 4 pre-sanctioning, and (2) finish recontracting its recently acquired KFS WI capacity before pursuing an expansion. Our 2024 EBITDA forecast increases 3 per cent while 2024 estimated DCFPS declines 5 per cent due to guidance for higher-than-expected cash taxes and maintenance capex. ... We continue to like its peer-leading growth rates and strong balance sheet, seeing further upside."